Researchers at Queen’s have developed a highly innovative new enzyme biomarker test that has the potential to indicate diseases and bacterial contamination saving time, money and possibly lives.
The test, developed by scientists at the Institute for Global Food Security (IGFS) at Queen’s, can detect enzyme markers of disease known as proteases in humans, animals and food products.
Proteases are crucial for microorganism growth and are responsible for the progression of many diseases.
Levels of these enzyme markers can be highly elevated in the urine of patients with diabetic kidney disease, or at the sites of infected wounds. Similarly, in cows, an elevation of proteases in their milk can reveal diseases such as bovine mastitis, a type of mammary gland infection. In food, proteases produced by bacteria contaminated in meat and dairy products can lead to rancidity, as well as decreased shelf life and quality.
Current protease detection methods are costly, time-consuming and are not always effective. Scientists at the IGFS have developed a nanosensor which has resulted in sensitive, fast and cost-effective protease detection in milk and urine.
Dr Claire McVey, Queen’s researcher and co-author on the study published in leading journal Nano Research, explained: “Not only is the test cheap to produce, but it can be used anywhere and is not reliant on laboratory conditions.
“Eliminating the need to carry out tests in a laboratory setting is life-changing. As well as being cost-effective, it means faster diagnosis.”
The gold-nanoparticle based nanosensor devised by Queen’s researchers indicates when proteases are present through a visible colour-change reaction. Gold nanoparticles are well known for their capability in speeding up the oxidization of a chemical called tetramethylbenzidine (TMB), visible through a vivid blue-colour formation.
When casein (a molecule present in milk) is added to gold nanoparticles, it surrounds the nanoparticles acting as a protective surface barrier. When TMB is introduced, the casein prevents the oxidization reaction meaning there is no or only a slight colour change.
Where proteases are present, they ‘eat’ the protective casein barrier, exposing the surface of the gold nanoparticles. In this instance, when TMB is added, the proteases have removed the casein meaning oxidization occurs quickly causing a fast change in colour.
Queen’s researcher Dr Cuong Cao, a Lecturer in Advanced Micro- and Nano-Diagnostics, and the lead academic on the study: “When we add TMB to the casein-covered gold nanoparticles, we can tell virtually instantly if proteases are present by whether or not the solution turns blue. Normally such testing takes much longer.”
Using this approach, proteases can be detected within 90 minutes without the need for complicated or expensive laboratory equipment.
In addition, the ‘ingredients’ for making the nanosensor are readily available and low cost. Gold nanoparticles can be produced in abundance, with little restriction on storage requirements, making it a durable and cheap substance.
The approach developed by the Queen’s researchers was tested on milk and urine but it could be adapted for a number of other applications. Dr Cao explained: “Using molecules other than casein to coat the surface has the potential to detect other types of enzyme biomarkers. For example, coating the nanoparticles with lipids could detect the lipase enzyme, which could help in the diagnosis of diseases such as pancreatitis.
“Following full validation of this test, we would like to explore how we could expand the application to detect a host of other diseases or contaminated foods.
“This new approach will enable the identification of enzyme biomarkers at the point of care. It could change the landscape of how enzyme biomarkers are detected and diagnosed, making an impact not only on food safety, but on the diagnosis of enzyme-related illnesses among animals and humans.
“The potential scope for this test is huge.”
Professor Chris Elliott, founder of the Institute for Global Food Security and a co-investigator in the study commented: “The ability to diagnose disease or contamination quickly can have a huge impact on how serious problems can be dealt with.
“The ultra-low cost of the system will help reduce costs of testing and could transform the amount of testing performed in the developing world.”
The Latest on: Enzyme biomarker
via Google News
The Latest on: Enzyme biomarker
- Renal Biomarker Market: Manufacturer 's Revenue all Realized Positive Growthon September 6, 2019 at 4:22 am
Pharmacodynamic Biomarkers), Application (Hospital, Diagnostic Laboratory, Other), Diagnostic Technique (Enzyme-linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), ...
- Ribon Therapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of RBN-2397, a First-In-Class PARP7 Inhibitoron September 4, 2019 at 10:24 am
PARP7 belongs to a family of enzymes activated under cellular stress ... and to explore pharmacodynamic readouts and predictive biomarkers. The study is comprised of a dose escalation phase ...
- Proteomic profiling of extracellular vesicles allows for human breast cancer subtypingon September 3, 2019 at 2:12 am
Therefore, currently reported BC biomarkers are mostly generic cancer markers ... Richmond, VA, USA) for 4 h (enzyme/substrate ratio 1:75) at 37 °C. Samples were diluted four times and digested ...
- Cancer could be detected with a URINE test, scientists hopeon September 2, 2019 at 11:03 pm
If cancer is present, enzymes released by tumours called protaeses cut the ... Current diagnostic tools for cancer sometimes rely on biological signals known as biomarkers, which are produced when ...
- Odiparcil development advances with recruitment of first patients in a new biomarker study in MPS VI children and adults Paris Stock Exchange:IVAon September 2, 2019 at 3:09 pm
A first biomarker study sponsored by Inventiva showed ... after ERT infusion although the activity of the arylsulfatase B2 enzyme was very high. This finding suggests that leukoGAG levels may ...
- Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findingson September 1, 2019 at 11:30 pm
About NT-proBNP NT-proBNP is a biomarker commonly used to assess the severity and ... Other common heart failure medicines, called angiotensin converting enzyme (ACE) inhibitors and angiotensin II ...
- Dipeptidyl Peptidase 3 (DPP3) Cause of Acute Myocardial Depression. Sphingotec Launches First IVD Test For DPP3 on Nexus IB10 Point-of-Care Platformon August 31, 2019 at 5:10 pm
The DPP3 biomarker indicates angiotensin II and enkephalin ... is an ubiquitously expressed and highly conserved enzyme. DPP3 cleaves various bioactive peptides, such as such as angiotensin ...
- 4TEEN4 Pharmaceuticals reports first results on Procizumabon August 31, 2019 at 2:11 pm
4TEEN4 licenses its proprietary biomarker DPP3 to make it available for diagnostic ... About DPP3 Human Dipeptidyl Peptidase 3 (DPP3) is an ubiquitously expressed and highly conserved enzyme. DPP3 ...
- Dipeptidyl Peptidase 3 (DPP3) cause of acute myocardial depressionon August 31, 2019 at 2:11 pm
The DPP3 biomarker indicates angiotensin II and enkephalin signaling ... About DPP3 Human Dipeptidyl Peptidase 3 (DPP3) is an ubiquitously expressed and highly conserved enzyme. DPP3 cleaves various ...
- New information on regulation of sense of smell with the help of nematodeson August 27, 2019 at 9:37 am
PIM kinases are enzymes that are evolutionarily well conserved ... this phenomenon could even be used as a biomarker to assess the efficacy of the PIM-targeted therapies that are currently being ...
via Bing News